4.3 Article

Get With The Guidelines AFIB Novel Quality Improvement Registry for Hospitalized Patients With Atrial Fibrillation

Journal

CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES
Volume 7, Issue 5, Pages 770-777

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/CIRCOUTCOMES.114.001263

Keywords

antiarrhythmia agents; anticoagulants; atrial fibrillation; atrial flutter; quality assurance, health care

Funding

  1. ARCA Biopharma
  2. GE Healthcare
  3. ResMed
  4. Johnson Johnson
  5. Spectranetics
  6. Medtronic
  7. Gilead Sciences
  8. St Jude Medical
  9. Precision Health Economics
  10. iRhythm
  11. American Heart Association (AHA)
  12. Veterans Administration
  13. Boehringer Ingelheim
  14. Jannsen Pharmaceuticals
  15. Sanofi Aventis
  16. Pfizer
  17. Bristol Myers Squibb
  18. Janssen
  19. Daiichi Sankyo
  20. Biosense Webster

Ask authors/readers for more resources

Background-Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia. It is a cause of stroke, heart failure, and death. Guideline-based treatment can improve outcomes in AF. Unfortunately, adherence to these guidelines is low. Get With The Guidelines is a hospital-based performance initiative, which has been shown to improve adherence over time. Get With The Guidelines-AFIB is a novel quality improvement registry designed to improve adherence to AF guidelines. Methods and Results-Hospitals will be recruited by regional American Heart Association staff and key stakeholders. Inpatients or observed patients with AF or atrial flutter will be enrolled. Data collected will include demographic, medical history, and clinical characteristics including laboratory values and treatments. Decision support will guide adherence to achievement and quality measures designed to improve adherence to anticoagulation, heart rate control, safe antiarrhythmic drug use, and patient education and follow-up. Increased adherence to guidelines will be facilitated using rapid-cycle quality improvement, site-specific reporting including national and regional benchmarks and hospital recognition for achievement. Primary analyses will include adherence to American Heart Association/American College of Cardiology performance measures and guidelines. Secondary analyses will include processes of care, risk stratification, treatment of special conditions or populations and use of particular treatment techniques. Conclusions-AF is common clinical problem with significant morbidity and mortality. Get With The Guidelines-AFIB is a national hospital-based AF quality improvement program designed to increase adherence to evidence-based guidelines for AF.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available